Nanoantibodies for detection and blocking of bioactivity of human vascular endothelial growth factor a165


Nanoantibodies (single-domain antibodies, nanobodies) derived from noncanonical single-chain immunoglobulins provide an attractive tool for in vitro and in vivo diagnostics as well as for development of targeted drugs for clinical use. Nanoantibodies against several clinically important targets have been developed and are actively investigated. However, no… (More)
DOI: 10.1134/S0006297912060132


3 Figures and Tables